Boston Scientific was among the participants in the urological cancer device developer's first funding round, as it prepares for US trials late next year.
Francis Medical, a US-based medical device developer targeting prostate cancer, has received $18m in series A funding from a consortium including medical device producer Boston Scientific.
Venture capital firm Arboretum Ventures led the A round, which also featured H2Oey Ventures, an affiliate of Solas BioVentures Fund, and family office Tonkawa.
Francis Medical is working on a minimally-invasive device that will treat urological cancer using water vapour. It raised the cash following feasibility trials in the Dominican Republic, Paraguay and Panama.
…
